JW Lifescience Market Cap

JW Lifescience has a market cap or net worth of 193.40 billion as of March 9, 2026. Its market cap has increased by 18.50% in one year.

Market Cap

193.40B

Enterprise Value

216.46B

Revenue

248.30B

Ranking

n/a

PE Ratio

4.06

Stock Price

12,490.00

Market Cap Chart

Since October 27, 2016, JW Lifescience's market cap has decreased from 340.05B to 193.40B, a decrease of -43.12%. That is a compound annual growth rate of -5.84%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	193.40B	-2.80%
Dec 30, 2025	198.98B	18.11%
Dec 30, 2024	168.47B	-15.46%
Dec 28, 2023	199.29B	5.93%
Dec 29, 2022	188.14B	-12.27%
Dec 30, 2021	214.46B	-34.73%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AptaBio Therapeutics	193.84B
REYON Pharmaceutical	191.66B
Jeil Pharmaceutical Co.,Ltd	210.56B
HLB Pharmaceutical	212.04B
Samjin Pharmaceuticals	222.85B
Samil Pharmaceutical Co.,Ltd	223.34B
SAMSUNG PHARM. Co., LTD.	175.44B
Daewon Pharmaceutical	229.34B

Market Cap Rankings